Log in to save to my catalogue

Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type...

Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4dd8f9e3c6f542a4b4d9938ecef5e221

Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A

About this item

Full title

Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-10, Vol.11 (1), p.20513-20513, Article 20513

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Metachromatic leukodystrophy (MLD) is a lysosomal storage disease caused by an arylsulfatase A (ARSA) deficiency and characterized by severe neurological symptoms resulting from demyelination within the central and peripheral nervous systems. We investigated the feasibility and efficacy of intrathecal administration of a type 9 adeno-associated vir...

Alternative Titles

Full title

Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4dd8f9e3c6f542a4b4d9938ecef5e221

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4dd8f9e3c6f542a4b4d9938ecef5e221

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-99979-2

How to access this item